Overview

8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of the valsartan/aliskiren combination compared to valsartan alone in patients with Stage 2 hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Valsartan